Flector
Product Images NDC 42254-248

6 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flector (NDC 42254-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (2b810942 E143 4e4f 8820 00af4f2e0c1e 01)

Chemical Structure (2b810942 E143 4e4f 8820 00af4f2e0c1e 01)
Chemical structure diagram showing diclofenac and epolamine, with their molecular frameworks and specific functional groups labeled, including chloro substituents on diclofenac and the pyrrolidin-1-yl ethanol component of epolamine.*
FDA Label Image

Figure 1 (2b810942 E143 4e4f 8820 00af4f2e0c1e 02)

Figure 1 (2b810942 E143 4e4f 8820 00af4f2e0c1e 02)
A scatter plot comparing the percentage of patients improved versus percent improvement from baseline for Diclofenac Patch and Placebo. The graph uses solid circles for Diclofenac Patch and open squares for Placebo, illustrating higher patient improvement with Diclofenac Patch across improvement percentages.*
FDA Label Image

Figure 2 (2b810942 E143 4e4f 8820 00af4f2e0c1e 03)

Figure 2 (2b810942 E143 4e4f 8820 00af4f2e0c1e 03)
A line graph comparing the percent of patients improved over the percent improvement from baseline between Diclofenac Patch and Placebo. The Diclofenac Patch line shows consistently higher improvement percentages than the Placebo across the range.*
FDA Label Image

Figure 3 (2b810942 E143 4e4f 8820 00af4f2e0c1e 04)

Figure 3 (2b810942 E143 4e4f 8820 00af4f2e0c1e 04)
Line chart showing percent of patients improved over percent improvement from baseline, comparing Diclofenac Patch with Placebo. The chart uses filled circles for Diclofenac Patch and open squares for Placebo, illustrating a higher improvement trend for the Diclofenac Patch.*
FDA Label Image

Figure 4 (2b810942 E143 4e4f 8820 00af4f2e0c1e 05)

Figure 4 (2b810942 E143 4e4f 8820 00af4f2e0c1e 05)
A line graph comparing the percent of patients improved versus percent improvement from baseline, showing data for two groups: Diclofenac Patch and Placebo. The graph demonstrates higher patient improvement percentages with the Diclofenac Patch across increasing levels of improvement.*
FDA Label Image

Flector 1.3% (2b810942 E143 4e4f 8820 00af4f2e0c1e 06)

Flector 1.3% (2b810942 E143 4e4f 8820 00af4f2e0c1e 06)
Flector 1.3% Patch packaging label from Rebel Distributors Corp, NDC 42254-248-30. The label states each patch contains 180mg Diclofenac Epolamine in an aqueous adhesive base with a strength of 1.3%. The package contains 30 patches measuring 10cm x 14cm. Manufacturer is Teikoku Seiyaku Co., Ltd, Japan. Storage and safety information is printed in a red box at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.